BridgeMD
New treatment option for Family Centered
Official title Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers
ClinicalTrials.gov ID: NCT07164456
What this study is testing
- What it's testing
- To establish the efficacy of the family-centered intervention in improving healthy lifestyle behaviors (MVPA and overall diet quality), as well as physical functioning, QoL, and family health climate, compared to survivor-only and control groups.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Eligibility Criteria Survivors are eligible if they
- Are adults (≥18 years old)
- Self-identify as Black or African American;
- Were diagnosed with stage 0-III PCa; completed PCa treatment; (5) are able to be physically active, as determined by responses to the Physical...
- Have a family caregiver willing to participate together. Individuals under active surveillance for PCa will be included. Caregivers are eligible if...
You likely can't join if
- Survivors are excluded if they:
- Have a prior history of other cancer or have metastatic cancer.
- Have planned concomitant immunotherapy, hormonal therapy, chemotherapy, or radiation therapy during the study period.
- Meet physical activity recommendations (i.e., 150 min of moderate intensity physical activity per week); and (4) are currently participating in a...
- Have serious medical conditions (e.g., cancer, congestive heart failure, stroke, and dementia)
- Are currently participating in a lifestyle or weight management program.
See the full eligibility criteria
- Eligibility Criteria Survivors are eligible if they
- Are adults (≥18 years old)
- Self-identify as Black or African American;
- Were diagnosed with stage 0-III PCa; completed PCa treatment; (5) are able to be physically active, as determined by responses to the Physical Activity Readiness Questionnaire (PAR-Q); and
- Have a family caregiver willing to participate together. Individuals under active surveillance for PCa will be included. Caregivers are eligible if they:
- Are adults (≥18 years old)
- Are able to be physically active, as determined by responses to the
- Survivors are excluded if they:
- Have a prior history of other cancer or have metastatic cancer.
- Have planned concomitant immunotherapy, hormonal therapy, chemotherapy, or radiation therapy during the study period.
- Meet physical activity recommendations (i.e., 150 min of moderate intensity physical activity per week); and (4) are currently participating in a lifestyle or weight management program. Caregivers are excluded if they:
- Have serious medical conditions (e.g., cancer, congestive heart failure, stroke, and dementia)
- Are currently participating in a lifestyle or weight management program.
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.